- Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
-
Kwon SH, Jeong SW, Jang JY, Lee JE, Lee SH, Kim SG, Kim YS, Cho YD, Kim HS, Kim BS, Jin SY
- KMID: 1392908
- Clin Mol Hepatol.
- 2012 Sep;18(3):287-294.
- doi: 10.3350/cmh.2012.18.3.287
BACKGROUND/AIMS: Cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) are up-regulated in hepatocellular carcinoma (HCC). To investigate the levels of COX-2 and VEGF expression in chronic hepatitis (CH), cirrhosis, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastric pH and Helicobacter pylori Infection in Patients with Liver Cirrhosis
-
Nam YJ, Kim SJ, Shin WC, Lee JH, Choi WC, Kim KY, Han TH
- KMID: 760555
- Korean J Hepatol.
- 2004 Sep;10(3):216-222.
BACKGROUND/AIMS: Data from previous studies on gastric acid secretion and the prevalence of H. pylori in liver cirrhosis patients remain poorly defined. H. pylori is a potential source of... -
- CITED
-
- Close
- SHARE
-
- Close
- HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1
-
Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, Jang SK, Yang SH, Sung YC, Kwon OJ, Yoon SK
- KMID: 755753
- Exp Mol Med.
- 2005 Apr;37(2):138-145.
Liver cirrhosis is one of the major complications of hepatitis C virus (HCV) infection, but the mechanisms underlying HCV-related fibrogenesis are still not clear. Although the roles of HCV core... -
- CITED
-
- Close
- SHARE
-
- Close
